Volume 17, Number 6—June 2011
Research
Multiple Introductions of Multidrug-Resistant Tuberculosis into Households, Lima, Peru
Table A1
House ID no. | Patient age, y/sex | Date | MIRU-VNTR pattern | Spoligotype | ST | Lineage | Drug susceptibility, SHRECFYTKZALP† |
---|---|---|---|---|---|---|---|
4‡ | 21/M | 1997 Feb 1 | 2 2 2 3 3 2 4 2 2 6 1 5 3 2 3 3 3 4 2 1 2 3 + 2 | 736177607700171 | 1476 | U | SRRSSSSSSSXXX |
22/M |
1997 Jan 14 |
3 2 3 3 3 2 4 3 1 5 1 5 3 2 4 4 3 4 2 3 4 3 6 3 |
777740777760771 |
219 |
T1 |
SRRXSSSSSRXXX |
|
112 | 19/M | 2001 Nov 14 | 4 2 4 3 2 2 4 3 2 1 1 4 3 2 4 3 3 4 2 3 4 3 2 2 | 777777777760771 | 53 | T1 | RRRRRSSSRSRSS |
25/M |
2001 Nov 13 |
4 2 4 3 5 2 3 3 2 1 1 4 3 2 4 3 3 4 2 3 4 3 2 2 |
777777777760771 |
53 |
T1 |
RRRRRSSRRRRSS |
|
126‡ | 27/M | 2001 May 7 | 2 1 4 3 3 2 4 2 2 6 1 5 3 2 1 5 2 4 1 5 3 4 8 2 | 777777607760771 | 42 | LAM9 | RRRRSSSRSRSSS |
22/F |
2001 May 2 |
2 1 2 3 2 1 4 3 2 7 1 5 3 2 8 4 2 4 1 4 3 1 5 2 |
777400007760771 |
1594 |
T1 |
RRRRSRSRSRSRS |
|
192 | 29/F | 2000 Feb 25 | 2 1 5 3 3 2 3 1 2 4 1 2 2 1 1 5 3 4 1 5 3 3 8 2 | 777777607760731 | 60 | LAM4 | RRRRSRSSSRXXX |
23/F |
2001 May 31 |
2 1 5 3 3 2 3 1 2 4 1 2 2 2 1 4 3 4 1 5 3 3 8 2 |
777777607760731 |
60 |
LAM4 |
RRRRSSSRSRXSS |
|
361‡ | 27/M | 1998 May 20 | 3 2 3 2 3 2 5 3 2 5 1 4 3 2 2 5 3 4 1 3 4 5 4 3 | 700036777760771 | 91 | X3 | RRRRXXXXXRXXX |
26/F |
1999 Mar 1 |
4 2 4 3 2 2 3 3 2 1 1 5 3 2 4 3 3 4 2 3 4 3 2 2 |
777777777760771 |
53 |
T1 |
XRRSSSSSSRXXX |
|
517‡ | 66/F | 2002 May 7 | 3 2 3 3 3 2 4 3 2 5 1 4 3 2 2 3 4 4 4 3 4 6 6 3 | 700036777760771 | 91 | X3 | RRRRSSSSSRSSS |
30/M |
2001 Nov 21 |
4 2 3 3 3 2 3 3 2 1 1 5 3 2 4 3 3 4 2 3 4 3 2 2 |
777777777760771 |
53 |
T1 |
RRRSSSSSSSSSS |
|
557 | 24/M | 2003 Apr 25 | 3 2 3 3 3 2 5 3 2 5 1 5 3 2 3 3 2 4 4 3 5 4 7 3 | 777777777720761 | ND | ND | RRRRSSSRRSRSS |
18/M |
2002 Oct 9 |
3 2 3 3 3 2 5 3 2 5 1 5 3 2 3 3 2 4 4 3 4 5 7 3 |
777777777720771 |
50 |
H3 |
SRRRSSSRSSSSS |
|
685‡ | 19/F | 2003 Apr 4 | 3 2 3 3 3 2 5 3 2 5 1 5 3 2 3 3 2 4 4 3 6 5 7 3 | 777777707720771 | 512 | H3 | SRRRSSSSSRSSS |
30/M |
2003 Jul 17 |
4 2 4 3 2 2 3 3 2 1 1 5 3 2 4 3 3 4 2 3 4 3 2 2 |
777777777760771 |
53 |
T1 |
SRRRSSSSSRSSS |
|
960 | 19/F | 2002 Jul 18 | 1 1 4 3 3 2 4 2 2 6 1 5 3 2 1 4 3 4 1 5 3 4 4 2 | 777737607760771 | 93 | LAM5 | RRRRSSSSSRSSS |
16/M |
2000 Aug 7 |
2 1 4 3 3 2 4 2 2 6 1 5 3 2 1 4 3 4 1 4 3 4 4 2 |
777737607760771 |
93 |
LAM5 |
RRRRSSSSSRXXX |
|
28‡ | 18/M | 2001 Feb 20 | 2 2 4 3 2 1 4 2 2 6 1 5 3 2 2 4 3 4 1 3 3 2 7 2 | 777774077560771 | 222 | T1 | SRRRSSSRSRXSS |
NA | 2002 May 25 | 4 2 4 3 2 2 3 3 2 1 1 5 3 2 4 3 3 4 2 3 4 3 2 2 | 777777777760771 | 53 | T1 | RRRRSSSSSRSSS | |
20/M |
2001 Aug 31 |
2 2 4 3 2 1 4 2 2 6 1 5 3 2 2 4 3 4 1 3 3 2 7 2 |
777774077560771 |
222 |
T1 |
SRRSSSSRSRSSS |
|
106‡ | 35/M | 1997 Aug 23 | 2 1 4 3 3 2 4 2 2 6 1 5 3 2 1 4 3 4 1 5 3 4 4 2 | 777737607760771 | 93 | LAM5 | SRRRSSSSSRXXX |
33/F | 2000 May 5 | 2 2 + 3 2 1 4 3 2 6 1 4 3 2 0 4 3 4 1 3 3 2 6 2 | 777777607760771 | 42 | LAM9 | RRRRSRSSSRXXX | |
15/M |
2000 Aug 29 |
2 2 + 3 2 1 4 3 2 6 1 4 3 2 0 4 3 4 1 3 3 2 6 2 |
777777607760771 |
42 |
LAM9 |
RRRSSSSSSRXXX |
|
263 | 75/F | 2002 Aug 7 | 3 2 3 3 3 2 5 3 2 5 1 4 3 2 2 8 2 2 1 3 4 4 6 3 | 700036777760771 | 91 | X3 | RRRRSSSRSRSSS |
19/F | 1997 Oct 25 | 3 2 3 3 3 2 5 3 2 5 1 4 3 2 2 5 2 2 1 3 4 4 6 3 | 700036777760771 | 91 | X3 | RRRRSSSRSRSXX | |
35/F | 1996 Dec 11 | 3 2 3 3 3 2 5 3 2 5 1 4 3 2 2 5 2 2 1 3 4 4 6 3 | 700036777760771 | 91 | X3 | RRRRSSSRSRXXX | |
16/F | 1996 Oct 17 | 3 2 3 3 3 2 5 3 2 5 1 4 3 2 2 5 2 2 1 3 4 4 7 3 | 700036777760771 | 91 | X3 | RRRRSSSRSSXXX | |
28/F |
1996 Oct 17 |
3 2 3 3 3 2 5 3 2 5 1 4 3 2 2 5 2 2 1 3 4 4 6 3 |
700036777760771 |
91 |
X3 |
RRRRRRSRSRSXX |
|
439‡ | 21/M | 2001 Oct 25 | 3 1 4 3 3 2 3 3 2 1 1 5 3 2 5 3 3 4 2 3 4 3 2 2 | 777777777460771 | 1905 | T1 | RRRRRRSRRRSSS |
19/M |
2002 Jun 17 |
2 2 4 3 2 1 4 3 2 6 1 5 3 2 2 4 4 4 1 3 3 2 5 2 |
777777407560731 |
1355 |
T2 |
RRRRSSSSSRSSS |
|
645 | 23/M | 2001 Nov 13 | 2 1 4 3 3 2 4 2 2 6 1 5 3 2 1 4 3 4 1 5 3 4 4 2 | 777737607760771 | 93 | LAM5 | SRRSSSSSSRSSS |
22/F | 2002 Jul 3 | 2 2 4 3 3 2 4 2 2 6 1 5 3 2 1 4 3 4 1 5 3 4 4 2 | 777737607760771 | 93 | LAM5 | SRRRSSSSSRSSS | |
27/F |
2001 Jan 24 |
2 1 4 3 3 2 4 2 2 6 1 5 3 2 1 4 3 4 1 5 3 3 4 2 |
777737607760771 |
93 |
LAM5 |
SRRRSSSSSRSSS |
|
976‡ | 27/F | 2002 Aug 27 | 4 1 4 3 2 2 3 3 2 1 1 5 3 2 4 3 3 4 2 3 4 3 2 2 | 777777777760771 | 53 | T1 | RRRRSSSSSRSSS |
26/M |
2002 Mar 30 |
3 2 3 3 3 2 3 3 2 5 1 4 3 2 2 5 3 4 4 3 4 7 6 3 |
700036777760771 |
91 |
X3 |
RRRRSSSSRRRSS |
|
977‡ | 19/M | 2003 Feb 21 | 2 2 4 3 3 2 4 3 2 6 1 5 3 2 3 3 3 4 2 1 2 4 7 2 | 776177607660731 | ND | ND | SRRRSSSSSRSSS |
46/F | NA | 4 2 4 3 5 2 3 3 2 5 1 7 3 3 3 5 5 4 4 3 4 6 8 2 | 000000000003731 | 190 | Beijing | SRRRSSSRRRSSS | |
20/M | 2002 Jul 5 | 2 2 4 3 3 2 4 3 2 6 1 5 3 2 3 3 3 4 2 1 2 3 7 2 | 776177607660731 | ND | ND | RRRRSSSRSSSSS |
*MDR TB, multidrug-resistant tuberculosis; ID, identification, MIRU-VNTR, mycobacterial interspersed repetitive unit–variable number tandem repeat; ST, shared type; ND, not determined because ST and lineage could not be assigned on the basis of spoligotype; NA, not available.
†Antimicrobial drugs tested were streptomycin (S), isoniazid (H), rifampin (R), ethambutol (E), capreomycin (C), ciprofloxacin (F), cycloserine (Y), ethionamide (T), kanamycin (K), pyrazinamide (Z), amikacin (A), levofloxacin (L), and p-amino salicylic acid (P). Susceptibility patterns: S, susceptible; R, resistant; X, no result.
‡These 10 households were ultimately categorized as probable settings of multiple MDR TB introductions for subsequent analysis.
Page created: August 03, 2011
Page updated: August 03, 2011
Page reviewed: August 03, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.